Exploring the genetic basis of disease using RNA interference

Expert Review of Molecular Diagnostics

Volumn 4, Issue 5, 2004, Pages 645-651

  Kissler, Stephan ^a   Van Parijs, Luk ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Autoimmunity; Cancer; Diabetes; Disease model; Genetics; Lentivirus; RNAi

Indexed keywords

DOUBLE STRANDED RNA;

AUTOIMMUNITY; CANCER; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; DNA PROBE; GENE LOCUS; GENE SILENCING; GENETIC ANALYSIS; GENETIC MANIPULATION; GENETIC POLYMORPHISM; GENETIC SCREENING; IN VIVO STUDY; INBRED STRAIN; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT GENE; MULTIFACTORIAL INHERITANCE; MULTIPLE SCLEROSIS; NONHUMAN; REGULATORY MECHANISM; REVIEW; RNA INTERFERENCE; TRANSCRIPTION REGULATION;

ANIMALS; AUTOIMMUNE DISEASES; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENETIC TECHNIQUES; GENETIC VECTORS; LENTIVIRUS; MICE; MICE, TRANSGENIC; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 4544381289     PISSN: 14737159     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737159.4.5.645     Document Type: Review

References (59)

1. Malumbres M, Carnero A. Cell cycle deregulation: a common motif in cancer. Prog. Cell Cycle Res. 5, 5-18 (2003).
2. Jaattela M. Multiple cell death pathways as regulators of tumor initiation and progression. Oncogene 23, 2746-2756 (2004).
3. Gerald WL. Genome-wide gene expression analysis of prostate carcinoma. Semin. Oncol. 30, 635-648 (2003).
4. Russo G, Zegar C, Giordano A. Advantages and limitations of microarray technology in human cancer. Oncogene 22, 6497-6507 (2003).
5. Cowgill SM, Muscarella P. The genetics of pancreatic cancer. Am. J. Surg. 186, 279-286 (2003).
6. Muller H, Plasilova M, Russell AM, Heiniman K. Genetic predisposition as a basis for chemoprevention, surgical and other interventions in colorectal cancer. Recent Results Cancer Res. 163, 235-247 (2003).
7. Greaves MF, Maia AT, Wiemels JL, Ford AM. Leukemia in twins: lessons in natural history. Blood 102, 2321-2333 (2003).
8. Oliveira C, Seruca R, Caldas C. Genetic screening for hederitary diffuse gastric cancer. Expert Rev. Mol. Diagn. 3, 201-215 (2003).
9. Balmain A, Gray J, Ponder B. The genetics and genomics of cancer. Nature Genet. 33(Suppl.), 238-244 (2003).
10. Dragani TA. 10 years of mouse cancer modifier loci: human relevance. Cancer Res. 63, 3011-3018 (2003).
11. Encinas JA, Kuchroo VK. Mapping and identification of autoimmunity genes. Curr. Opin. Immunol. 12(6), 691-697 (2000).
12. Kalman B, Albert RH, Leist TP. Genetics of multiple sclerosis: determinants of autoimmunity and neurodegeneration. Autoimmunity 35, 225-234 (2002).
13. Harney S, Wordsworth BP. Genetic epidemiology of rheumatoid arthritis. Tissue Antigens 60, 465-473 (2002).
14. Wong FS, Wen L. The study of HLA class II and autoimmune diabetes. Curr. Mol. Med. 3, 1-15 (2003).
15. Donaldson PT, Czaja AJ. Genetic effects on susceptibility, clinical expression, and treatment outcome of Type I autoimmune hepatitis. Clin. Liver Dis. 6, 419-437 (2002).
16. Wakeland EK, Liu K, Graham RR, Behrens TW. Delineating the genetic basis of systemic lupus erythematosus. Immunity 15, 397-408 (2001).
17. Rieux-Laucat F, Le Deist F, Fischer A. Autoimmune lymphoproliferation syndromes: genetic defect of apoptosis pathways. Cell Death Differ. 10, 124-133 (2003).
18. Tait BD, Colman PG, Morahan G et al. HLA genes associated with autoimmunity and progression to disease in Type 1 diabetes. Tissue Antigens 61, 146-153 (2003).
19. Barcellos LF, Oksenberg JR, Begovich AB et al. HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. Am. J. Hum. Genet. 72, 710-716 (2003).
20. Hayashi T, Faustman DL. Role of defective apoptosis in Type I diabetes and other autoimmune diseases. Recent Prog. Horm. Res. 58, 131-153 (2003).
21. Anderson MS, Venanzi ES, Klein L et al. Projection of an immunological self shadow within the thymus by the aire protein. Science 298, 1395-1401 (2002).
22. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806-811 (1998). First description of RNA interference (RNAi) by double-stranded RNA.
23. McManus MT, Sharp PA. Gene silencing in mammals by small interfering RNAs. Nature Rev. Genet. 3, 737-747 (2002).
24. Hannon GJ. RNA interference. Nature 418, 244-251 (2002).
25. Cunningham JM, McDonnell SK, Marks A et al. Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study. Prostate 57, 335-346 (2003).
26. MacGregor AJ, Snieder H, Schork NJ, Spector TD. Twins. Novel uses to study complex traits and genetic diseases. Trends Genet. 16(3), 131-134 (2000).
27. Singer GG, Carrera AC, Marshak-Rothstein A, Martinez C, Abbas AK. Apoptosis, Fas and systemic autoimmunity: the MRL-lpr/lpr model. Curr. Opin. Immunol. 6, 913-920 (1994).
28. 't Hart BA, Amor S. The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous system. Curr. Opin. Neurol. 16, 375-383 (2003).
29. Makino S, Kunimoto K, Muraoka Y, Mizushima Y, Katagiri K, Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu. 29, 1-13 (1980). Describes for the first time a mouse strain susceptible to spontaneous Type I diabetes.
30. Todd JA, Wicker LS. Genetic protection from the inflammatory disease Type 1 diabetes in humans and animal models. Immunity 15, 387-395 (2001).
31. Tuschl T, Zamore PD, Lehmann R, Bartel DP, Sharp PA. Targeted mRNA degradation by double-stranded RNA in vitro. Genes Dev. 13, 3191-3197 (1999).
32. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD. Asymmetry in the assembly of the RNAi enzyme complex. Cell 115, 199-208 (2003).
33. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage differentiation. Science 303, 83-86 (2004).
34. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
35. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498 (2001).
36. Zamore PD, Tuschl T, Sharp PA, Bartel DP. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101, 25-33 (2000).
37. Fraser AG, Kamath RS, Zipperlen P, Martinez-Campos M, Sohrmann M, Ahringer J. Functional genomic analysis of C. elegans chromosome I by systematic RNA interference. Nature 408, 325-330 (2000).
38. Gonczy P, Echeverri G, Oegema K et al. Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III. Nature 408, 331-336 (2000).
39. Paddison PJ, Silva JM, Conklin DS et al. A resource for large-scale RNA-interference-based screens in mammals. Nature 428, 427-431 (2004). First large-scale small-interfering RNA (siRNA) libraries used for the systematic study of genes.
40. Berns K, Hijmans EM, Mullenders J et al. A large-scale RNAi screen in human cells identifies new components of the p53 pathway. Nature 428, 431-437 (2004). First large-scale siRNA libraries used for the systematic study of genes.
41. McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA. RNA interference in adult mice. Nature 418, 38-39 (2002).
42. Lewis DL, Hagstrom JE, Loomis AG, Wolff JA, Herweijer H. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nature Genet. 32, 107-108 (2002).
43. Zender L, Hutker S, Liedtke C et al. Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc. Natl Acad. Sci. USA 100, 7797-7802 (2003).
44. Paddison PJ, Caudy AA, Bernstein E, Hannon GJ, Conklin DS. Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells. Genes Dev. 16, 948-958 (2002).
45. Brummelkamp TR, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553 (2002). Demonstrates for the first time that short-hairpin RNA (shRNA) can be expressed from viral vectors for stable RNAi in cultured cells.
46. Hommel JD, Sears RM, Georgescu D, Simmons DL, DiLeone RJ. Local gene knockdown in the brain using viral-mediated RNA interference. Nature Med. 9, 1539-1544 (2003).
47. Xia H, Mao Q, Paulson HL, Davidson BL. siRNA-mediated gene silencing in vitro and in vivo. Nature Biotechnol. 20, 1006-1010 (2002).
48. Dykxhoorn DM, Novina CD, Sharp PA. Killing the messenger: short RNAs that silence gene expression. Nature Rev. Mol. Cell. Biol. 4, 457-467 (2003).
49. Rubinson DA, Dillon CP, Kwiatkowski AV et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nature Genet. 33, 401-406 (2003). Demonstrates that lentiviral vectors can be used for the generation of transgenic mice that constitutively express shRNA for gene silencing.
50. Wiznerowicz M, Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference. J. Virol. 77, 8957-8961 (2003).
51. Gupta S, Schoer RA, Egan JE, Hannon GJ, Mittal V. Inducible, reversible, and stable RNA interference in mammalian cells. Proc. Natl Acad. Sci. USA 101, 1927-1932 (2004).
52. Hill NJ, Lyons PA, Armitage N, Todd JA, Wicker LS, Peterson LB. NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM12 and NRAMP1 loci in humans. Diabetes 49, 1744-1747 (2000).
53. Wyllie S, Seu P, Goss JA. The natural resistance-associated macrophage protein 1 Slc11a1 (formerly Nramp1) and iron metabolism in macrophages. Microbes Infect. 4, 351-359 (2002).
54. Blackwell JM, Goswami T, Evans CA et al. SLC11A1 (formerly NRAMP1) and disease resistance. Cell Microbiol. 3, 773-784 (2001).
55. Malo D, Vogan K, Vidal S et al. Haplotype mapping and sequence analysis of the mouse nramp gene predict susceptibility to infection with intracellular parasites. Genomics 23, 51-61 (1994).
56. Vidal S, Tremblay ML, Govoni G et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J. Exp. Med. 182, 655-666 (1995).
57. Nencioni A, Sandy P, Dillon C, Kissler S, Blume-Jensen P, Van Parijs L. RNA interference for the identification of disease-associated genes. Curr. Opin. Mol. Ther. 6, 136-140 (2004).
58. Blau HM, Rossi FM. Tet B or not tet B: advances in tetracycline-inducible gene expression. Proc. Natl Acad. Sci. USA 96(3), 797-799 (1999).
59. Sauer B. Inducible gene targeting in mice using the Cre/lox system. Methods 14, 381-392 (1998).